Toxicity is the ultimate tiebreaker. Compare the high-stakes SG profile — neutropenia, infection, and primary G-CSF prophylaxis — against Dato−DXd’s unique challenges: ocular toxicity, mucositis, and ILD monitoring. Determine which drug’s safety profile is more challenging to manage in your daily practice.
